Azita Saleki Gerhardt Abb Vie Inc. (ABBV) insider trading activity

Azita Saleki Gerhardt is EVP, CHIEF OPERATIONS OFFICER of AbbVie Inc.. Currently has a direct ownership of 194,348 shares of ABBV, which is worth approximately $36.8 Million. The most recent transaction as insider was on Sep 24, 2024, when has been sold 25,630 shares (Common Stock, $0.01 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 194K

11.65% 3M change

2.37% 12M change

Total Value Held $36.8 Million

AZITA SALEKI-GERHARDT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 24 2024	SELL Bona fide gift	-	25,630 Reduced 11.65%	194,348 Common Stock, $0.01 pa...
Feb 28 2024	SELL Payment of exercise price or tax liability	$4,289,674 $178.99 p/Share	23,966 Reduced 9.82%	219,978 Common Stock, $0.01 pa...
Feb 21 2024	SELL Open market or private sale	$9,184,047 $173.71 p/Share	52,870 Reduced 17.81%	243,944 Common Stock, $0.01 pa...
Feb 21 2024	BUY Exercise of conversion of derivative security	$3,112,985 $58.88 p/Share	52,870 Added 15.12%	296,814 Common Stock, $0.01 pa...
Feb 15 2024	BUY Grant, award, or other acquisition	-	54,095 Added 18.15%	243,944 Common Stock, $0.01 pa...
Mar 01 2023	SELL Open market or private sale	$5,689,431 $153.81 p/Share	36,990 Reduced 16.31%	189,849 Common Stock, $0.01 pa...
Mar 01 2023	BUY Exercise of conversion of derivative security	$1,387,825 $51.42 p/Share	26,990 Added 10.63%	226,839 Common Stock, $0.01 pa...
Feb 28 2023	SELL Payment of exercise price or tax liability	$5,146,626 $154.28 p/Share	33,359 Reduced 14.3%	199,849 Common Stock, $0.01 pa...
Feb 17 2023	SELL Open market or private sale	$3,739,750 $149.59 p/Share	25,000 Reduced 9.68%	233,208 Common Stock, $0.01 pa...
Feb 17 2023	BUY Exercise of conversion of derivative security	$1,285,500 $51.42 p/Share	25,000 Added 8.83%	258,208 Common Stock, $0.01 pa...
Feb 16 2023	BUY Grant, award, or other acquisition	-	75,296 Added 24.41%	233,208 Common Stock, $0.01 pa...
Feb 25 2022	SELL Payment of exercise price or tax liability	$3,306,030 $149.54 p/Share	22,108 Reduced 12.28%	157,912 Common Stock, $0.01 pa...
Feb 17 2022	BUY Grant, award, or other acquisition	-	63,736 Added 26.15%	180,020 Common Stock, $0.01 pa...
May 24 2021	SELL Open market or private sale	$10,123,573 $116.47 p/Share	86,920 Reduced 42.77%	116,284 Common Stock, $0.01 pa...
May 24 2021	BUY Exercise of conversion of derivative security	$2,830,115 $32.56 p/Share	86,920 Added 29.96%	203,204 Common Stock, $0.01 pa...
Feb 28 2021	SELL Payment of exercise price or tax liability	$1,700,676 $107.74 p/Share	15,785 Reduced 11.95%	116,284 Common Stock, $0.01 pa...
Feb 18 2021	BUY Grant, award, or other acquisition	-	35,628 Added 21.25%	132,069 Common Stock, $0.01 pa...
Nov 10 2020	SELL Open market or private sale	$1,707,748 $98.0 p/Share	17,426 Reduced 15.3%	96,441 Common Stock, $0.01 pa...
Nov 04 2020	SELL Open market or private sale	$449,328 $93.61 p/Share	4,800 Reduced 4.22%	109,067 Common Stock, $0.01 pa...
Feb 28 2020	SELL Payment of exercise price or tax liability	$1,395,934 $85.42 p/Share	16,342 Reduced 12.55%	113,867 Common Stock, $0.01 pa...
Feb 20 2020	BUY Grant, award, or other acquisition	-	36,897 Added 22.08%	130,209 Common Stock, $0.01 pa...
Mar 05 2019	SELL Open market or private sale	$1,248,437 $79.03 p/Share	15,797 Reduced 14.48%	93,312 Common Stock, $0.01 pa...
Feb 28 2019	SELL Payment of exercise price or tax liability	$998,104 $79.41 p/Share	12,569 Reduced 10.33%	109,109 Common Stock, $0.01 pa...
Feb 21 2019	BUY Grant, award, or other acquisition	-	28,366 Added 18.91%	121,678 Common Stock, $0.01 pa...
Feb 28 2018	SELL Payment of exercise price or tax liability	$1,499,892 $118.26 p/Share	12,683 Reduced 11.82%	94,649 Common Stock, $0.01 pa...

Also insider at

ENTG

ENTEGRIS INC Technology

Director